RaQualia Pharma Inc.
https://www.raqualia.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From RaQualia Pharma Inc.
Finance Watch: A Dozen Deals Add Up To $672m In Biopharma Venture Capital
Ventus Therapeutics raised a $140m series C while Endeavor Biomedicines brought in $101m in series B cash. Also, Twist Bioscience grossed $250m in a follow-on offering, BioMarin raised $110m when it sold a priority review voucher and Nuvectis, TC BioPharm launched IPOs.
Takeda Gets GI Candidate – And Possibly Company – In Altos Deal
In the latest in a string of deals, Takeda's agreement to acquire global rights to Altos's gastroparesis candidate - and possibly the company itself - gives the Japanese giant another asset in its core gastrointestinal area.
Japan Venture Taps ‘Deep Learning’ To Improve Drug Discovery
The Japanese peptide venture Interprotein is tapping into artificial intelligence technology with the hope of improving the efficiency and accuracy of its drug discovery efforts.
RaQualia links with academia to boost research, cut costs
RaQualia Pharma sees a new collaboration with Nagoya University as having two main benefits: aiding its effort to find innovative new drugs and helping to control operational expenses.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- AskAt Inc.